chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a male patient who received SHINGRIX for prophylaxis. On 20th August 2018, the patient received SHINGRIX. In August 2018, less than a week after receiving SHINGRIX, the patient experienced weakness, influenza and pain. On 20th August 2018, the patient experienced injection site pain, tenderness, numbness in hand, fever, headache, epigastric discomfort, sweating, chills and joint pain. On an unknown date, the outcome of the injection site pain, tenderness, numbness in hand, fever, headache, epigastric discomfort, sweating, chills, joint pain, weakness, influenza and pain were unknown. It was unknown if the reporter considered the injection site pain, tenderness, numbness in hand, fever, headache, epigastric discomfort, sweating, chills, joint pain, weakness, influenza and pain to be related to SHINGRIX. Additional details reported as follows: The age at vaccination was not reported. The patient received SHINGRIX this Monday at the conclusion of my annual physical. The patient had all of the listed side effects and then some, requiring me to lose a full day from work. On 20th August 2018, 1 day after vaccination, the patient experienced injection site pain, tenderness, numbness in hand, fever, headache, epigastric discomfort, sweating, chills and joint pain. On Monday afternoon, the patient had a sore arm at the injection site that spread to my entire upper arm, painful to even touch, with some numbness in the patient's hand. But the night of vaccination, the patient was awake with a fever that peaked at 101 degree F, a pounding headache, tightness in the patient's gut, sweating and chills, and aching in joints in the patient's arms and legs and had never had before. It was like the worst flu patient ever had. The patient was in bed for a day. The fever finally broke about 36 hours later and the patient was still weakened and sore from this episode. The patient had never had a reaction to any other vaccinations in my lifetime. The patient's doctor was questioning whether he should do the second shot in a few months, and he obviously don't want to go through this again. The patient asked happens if the second one was missed. Is it less effective, ineffective, or does it made me even more vulnerable to shingles? Is it reasonable to assume the second shot would be just as reactive as the first?
I started getting symptoms of loss of smell, fever, and tiredness. After one week, my smell came back. Then I had tingling and numbness on the left side of my body from the arms and up to my face with vertigo. I went to the ER and had tests done and had an EKG and ultrasound. This lasted in episodes for 5-6 weeks. I could not do my normal activities during this time. I went to my doctor and had an MRI and blood. My doctor thinks it could be an inflammation of the nerves. I am waiting for the results. This still happens to this day but more mild.
Pt had appointment for 3 vaccines: RSV, COVID, and flu. Most of the flu vaccine came out around the Luer-Lok needle. The pt said he did not feel vaccine enter his arm. The pt was scheduled to get valid dose one week later. PCP was contacted and did not want him to have another flu vaccine at this time.
I passed out, I was unconscious on the floor, my eyes were open and looked very strange he said, I was making gurgling sound.; I was unconscious on the floor/Tried to wake me up but it didn't work; Lethargic; This is a spontaneous report from a contactable consumer (patient).  A 82-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration at left arm on an unspecified date at single dose for COVID-19 immunization.  The patient medical history and concomitant medications were not reported.  The patient reported that: " I passed out the next morning for about 8 minutes my husband said, I was unconscious on the floor, my eyes were open and looked very strange he said, I was making gurgling sound. He threw water on me and he tried to wake me up but it didn't work. I came out of it I was very lethargic the whole day but the next day I was feeling a little bit better". No therapeutic measures were taken as a result of events. The patient outcome of lethargic was recovering; the outcome of the other events was recovered.  The information on the batch number has been requested.
Erythema, tenderness and warmth with moderate swelling at the site.  Arm pain to left arm. Fever, chills, body aches Severe headache and neck/back pain
Fever; This is a spontaneous report from a contactable consumer, the patient. A 12-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 16Jun2021 at 02:00 (at the age of 12-years-old) and also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the left arm on 07Jul2021 at 04:30 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any vaccine within four weeks prior to the COVID vaccine. On an unknown date in 2021, the patient experienced fever. The clinical outcome of event fever was unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Hives - face, neck, chest  diphenhydramine - 50 mg vitals normal approximately 20 mins later hives subsided in a few hours
Information has been received from a healthcare worker, medical assistant who reported that on unspecified dates, an unspecified number of unspecified patients received doses of improperly stored RECOMBIVAX HB (therapy type unknown, Lot numbers, expiration dates, dose and route were not reported). No adverse experiences were reported. This is one of several reports received from the same source. Additional information has been requested.
I currently cant even walk; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of unable to walk in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced unable to walk (Verbatim: I currently cant even walk). The outcome of the unable to walk was not resolved.   It was unknown if the reporter considered the unable to walk to be related to Shingles vaccine.     It was unknown if the company considered the unable to walk to be related to Shingles vaccine.   Additional Information: GSK receipt date: 20-JUN-2023 This case was reported the patient via interactive digital media. Patient asked not to do that. Vaccine screwed up the patient and currently the patient cannot even walk. Follow-up not possible as no contact details provided.
swollen at the injection site; bumpy at the injection site; itchy at the injection site; red at the injection site; Rough at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE MASS (bumpy at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE REACTION (Rough at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 31630A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE MASS (bumpy at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE REACTION (Rough at the injection site). At the time of the report, VACCINATION SITE SWELLING (swollen at the injection site), VACCINATION SITE MASS (bumpy at the injection site), VACCINATION SITE PRURITUS (itchy at the injection site), VACCINATION SITE ERYTHEMA (red at the injection site) and VACCINATION SITE REACTION (Rough at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       NO concomitant medications was included. no treatment details was provided.
swelling sl @ inj site; fever up to 104.1; stomach cramps; chills; sx devel w/in 24 hr of vax & persisted 48hr; PMD contacted & began tx w/Ibuprofen & APAP & inc fluids w/some improvement
I was 17 weeks pregnant at the time of my second dose. I woke up around 5am the morning after my vaccine with vomiting and weakness (low blood pressure). I could not keep down water and continued to vomit for a few hours. I called my OBGYN and she said to go get an IV done at urgent care to rehydrate. I probably would not have done this if it weren?t for being pregnant. I got the IV around 11am and then felt fine that evening (8pm onwards). I did not have any other adverse events after that.
Information has been received from a physician assistant concerning between a 12 to 14 year old female who on an unspecified date "a couple of weeks ago" was vaccinated with a first dose of Gardasil (lot # 655619/1427F) IM in the left deltoid at 10:35 AM. Concomitant therapy on the same day included DTaP-IPV. On the same day as the injection the patient experienced syncope within 5 minutes of receiving her first dose of Gardasil. Medical attention as sought. The patient recovered quickly and completely and walked out of the office. No additional information was provided. Follow-up information was received. The patient had no previous pertinent medical history, drug reactions/allergies or illness at the time of vaccination. The patient was ambulated to the bathroom after injections. The patient fainted at 10:45 AM while in the bathroom per mom. The patient was taken to the patient room. The patient's feet were elevated, skin was pale, unable to get a blood pressure reading, the patient was alert at 10:55 the patient felt better. The blood pressure measurement was 100/58. At 12:10 PM the patient left with mom, the skin was pink. The patient stated that she feels much better. On 07-SEP-2007, the patient recovered. Additional information has been requested.  Additional infromation is not expected.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 55-year-old male patient who received SHINGRIX for prophylaxis. On 29th March 2019, the patient received the 1st dose of SHINGRIX. On 29th March 2019, 2 hrs after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the patient experienced dry cough, productive cough, feeling down and fatigue. The patient was treated with ADVIL. On an unknown date, the outcome of the pain in arm, feeling down and fatigue were recovered/resolved and the outcome of the dry cough and productive cough were not recovered/not resolved. It was unknown if the reporter considered the pain in arm, dry cough, productive cough, feeling down and fatigue to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX vaccine on an unknown arm. The patient experienced arm pain that started 2 hours after the vaccine, and lasted about 4 hours until he took ADVIL that made him go to sleep. The patient woke up the next day with reduced arm pain. The was back to normal at the time of reporting. The patient felt run down for a couple of days and had symptoms of a wet and dry cough that's still going on. The patient's wet and dry cough has not resolved. The reporter did not consent to follow up with physician. This case has been linked with case US2019060937, reported by same reporter (for patient's wife).
HIVES/RASH ON RT HIP, HIVES AND RASH CONTINUED TO SPREAD ALL OVER BODY.  CURRENTLY IT IS WEEK 7 AND STILL HAVE HIVES AND RASH ALL OVER BODY.
They are painful; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Family history included ophthalmic herpes zoster (patient's mother had the shingles and almost went into her right eye and was miserable), shingles (patient's young nephew got shingles at a very young age) and shingles (patient's mother had the shingles).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: They are painful). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.   It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 12-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that he/she did not want the Shingles.  The patient got his/her two shingles vaccines several months ago.  They were painful but well worth having them instead of the consequences of not getting them.  The reporter stated that everyone should get their vaccines and their children instead of being made sick from all the viruses going around.  The reporter further stated that love your children enough to not put them in danger. The follow up would not possible as no contact details were available.
My son got the HPV vaccine on 1/2 and started having sinus pain on his right side about a day later. I took him to the doctor and they thought it was possible sinus pressure and slight fluid in his ear. He then had tooth pain on his right side, then in his right ear. By 1/10 he had extreme pain in his right ear. By 1/11 he had complaints of his eye feeling weird. By 1/12 we started noticing his Right eye wasn't closing all of the way and his mouth on was drooping on the right side. By 1/13 he didn't have any movement on the right side of his face. We took him to the dr and they believe it is Bell's palsy. He is now one antiviral and steroids. Hopefully he will get full function back in his right side of his face.
The patient was given a vaccine that was expired .  The vaccine had been left in the freezer longer than what the manufacture recommended .
PATIENT COMPLAINT SEVERE HEADACHE, RED AND SWOLLEN WHOLE RIGHT ARM, HIGH FEVER, CHILLS, RIDGES ON THE ARM.
Fever, body aches, headache lasting ~1 day; Fever; Body aches; This is a spontaneous report from a non-contactable pharmacist. A 29-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3247) via an unspecified route of administration on 29Mar2021 at 13:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant therapy were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications  within 2 weeks of vaccination. The patient had no reported allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 29Mar2021 the patient experienced fever, body aches, headache. It was mentioned that the events last less than a day. The patient did not receive any treatment for the event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever, body aches, headache was resolved on an unknown date.  No follow-up attempts are needed. No further information is expected.
Notified on April 6, 2018 that the shipment of MMR II was not viable because it was improperly stored, prior to delivery to our facility, because of inclement weather. This meant the vaccines were not viable according to standards and the patients needed to receive another vaccine. The shipment was received on March 23, 2018 and 7 patients received the vaccine prior to notification.
Information has been received from a physician concerning a 29 year old female "two days post delivery", still hospitalized after giving birth, who was vaccinated with a dose of MERUVAX II (manufacturer unknown). As standard protocol, she did not have evidence of immunity to rubella. Concomitant therapy included MOTRIN. "Within 12 hours" of vaccination the patient developed a rash on her side. The next day the patient developed arthralgia and difficulty breathing. She went to the ER for medical attention and was given oral and IV steroids. It was reported that the patient's experience improved on therapy (steroid treatment). No further information was provided. There was no product quality complaint involved. Additional information has been requested.
COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.    This case was linked to MOD-2021-283115 (Patient Link).
On 1/16/2021, the rash re-appeared on the site on injection and lower and has itchiness in that arm. Aside from feeling hot (no fever) and sweating at night and feeling very fatigues, my muscles were constantly twitching and I could not sleep through the night.  I would keep waking up and even felt like my hear rate had increased (felt higher than normal during these days). I was having frequent muscle aches on my arms and legs. My muscles either felt like they want to cramp or feel sore like if I was having carpal tunnel. I was having joint pain and tingling and cramping sensation on my calves, fingers, wrists.  On slight  1/15 and 1/16/21, I had slight congestion (burning sensation in nasal passages) and headache .  During that week I felt very off (not myself) and almost as if it had triggered my anxiety (not sure if it was related) and felt slightly lightheaded/dizzy.  I reached out to my primary care provider and she ordered labs to make sure potassium wasn't low or anything else abnormal going on. Labs came out normal.  I received second dose on 2/5/2021  (Moderna Lot #: 037K20A) and 8 weeks later, I am randomly having lymph node pain (under right armpit) which is the same side I received the vaccine, I randomly have been feeling like joint pain and feel slightly light headed (comes and goes).
Patient had brief reported LOC (<30s) observed by mom. Mom assisted to floor - and no fever, no injuries BP 104/64, Pulse 70, D-stick 94, Tolerated PO, observed x 20m and fully recovered.
12 yo female with history of ADHD presents with new onset seizure. Family was watching a movie and then she went to bed. Family heard her gasping and went into the room. She was on her side and had GTC movements of her arms and legs. Associated with blue color change to face. Lasted about 1 minute and stopped on its own. Color improved. Patient then sleepy after. Now back to baseline on arrival. Discharged from ER.
Patient was seen on 08/08/2018 received 2 vaccines MENACTRA and Tdap on each deltoid. Patient had large local reaction and tenderness. Fever off and on up 103 F, headache and abdominal pain.
Client came in 1/16/08 with macular erythematous lesion on lower extremities, macular erythematous pinpoint lesions to bilateral arms and stomach - Patient received Hep B #2 on 1/14/08 - left deltoid - no redness or swelling noted at injection site - Client did just change soap - Diagnosed by APNP with Rash - treated with Benadryl - on 1/18/08 - Rash was gone
always had normal kidney functions  lab normals for EGFR; greater than  59ml/min,  lab normals for creatine 0.57-1.00   . routine EGFR done 12/20/2020  67ML/min prior to 1st moderna. creatine 0.86  2/25/2021 5 days after second Moderna dose EGFR 56 ML/min, creatine .99 Repeat EGFR 5/21/2021 56 ML/min, creatine .99  may be permanent damage to kidneys
1st 24 hours itching (red bump, small). Next 4 hours upper arm swollen, red, large hard bump, very painful. 3rd day-entire back of upper arm red, large head bump painful.
Exanthematous rash around site of injection that was noticed 2 days after administration of the third dose of Moderna. No rash was noticed after the first two doses of Moderna.
No reported symptoms.; Syringe was somewhat faulty and vaccine leaked out as I was giving it to them; Patient received lower than authorized dose; This spontaneous case was reported by a pharmacist and describes the occurrence of SYRINGE ISSUE (Syringe was somewhat faulty and vaccine leaked out as I was giving it to them), UNDERDOSE (Patient received lower than authorized dose) and NO ADVERSE EVENT (No reported symptoms.) in a 38-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7180B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 28-May-2023, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 28-May-2023, the patient experienced SYRINGE ISSUE (Syringe was somewhat faulty and vaccine leaked out as I was giving it to them) and UNDERDOSE (Patient received lower than authorized dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No reported symptoms.). At the time of the report, SYRINGE ISSUE (Syringe was somewhat faulty and vaccine leaked out as I was giving it to them), UNDERDOSE (Patient received lower than authorized dose) and NO ADVERSE EVENT (No reported symptoms.) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No reported symptoms.) to be not related. No further causality assessments were provided for SYRINGE ISSUE (Syringe was somewhat faulty and vaccine leaked out as I was giving it to them) and UNDERDOSE (Patient received lower than authorized dose).    The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. No concomitant medication was reported. It was reported that no additional doses or treatments have been administered at this time. They previously called the provided recommendation to repeat dose or wait 8 weeks for risk of myocarditis or pericarditis.  This error was for the first bivalent booster and 4th dose in total. No other symptoms were reported . No treatment medication was reported.
rt arm swelling, redness, tenderness, warm from shoulder to elbow;mom applied warm compress q 2hr w/noticeably dec in swelling;6/4/99 mom stated much improved;
pt recvd vax;w/in 30 mins,exp an aluminium taste & soreness at inject site;sx lasted several hrs;
Heavy chest pain, trouble breathing, fatigue on day following vaccine.  Symptoms of chest pain remain but have lessened.
11/15/21 neuropathic pain noted to feet 11/19/21 neuropathic pain has spread to both upper and lower extremities. 11/22/21 provider appt - EMG ordered gabapentin initiated 11/26/21 neuropatic pain increased severly and an ER visit indicated negative COVID test, positive Strep test.  neurology consulted and 1gm Rocpehon Iv x 4 days initiated 11/30/21 neurology evalution with EMG & nerve conduction study revealed Acute Demylinating Polyradiculoneuropathy 12/1/21 Gammaguard infusions initiated X 5 doses.